| | | | | | | | Welcome to Editors' (re)View, a feature where the Pharma Manufacturing editors handpick notable pharma world happenings that deserve some extra consideration. See what you may have missed this week in pharma. |
|
|
|
| |
| | |
|
|
| | | | | The cell culture facility expansion will add large-scale production capacity as well as generate an additional 680 jobs by 2031. |
|
|
| In his decision, the judge pointed out that Lilly was attempting to use state laws to enforce federal regulations, which is the responsibility of the FDA. |
|
|
|
| |
| | |
|
|
| | | | | Politics, whether we like them or not, weigh heavy on manufacturing’s future. It's an election year, which means, global trade, regulations, immigration, national security and taxation will all be part of the national discourse. |
|
|
|
| |
| | |
|
|
| | | | Sponsored | | During tableting processes, APIs become airborne. These dust particles can harm workers, reduce air quality, contaminate products and cause explosions. Learn how dust collectors safely capture and contain airborne API dust before it causes problems. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|
